http://www.newswire.ca/en/releases/archive/January2005/06/c0426.html

Health Canada Approves New Cream Treatment for Skin Cancer
ALDARA is the first new treatment approved in Canada
for basal cell carcinoma in 30 years

Pro Golfer David Barr urges Canadians
to take action against skin cancer

TORONTO, Jan. 6 /CNW/ - Health Canada has approved ALDARA(TM)
(imiquimod)
Cream, 5%, a topical prescription medication for the treatment of
superficial
basal cell carcinoma (sBCC) - a form of non-melanoma skin cancer.
ALDARA is
the first new treatment for this type of cancer to be approved in
Canada in
close to 30 years and is the first in a new class of medications called
immune
response modifiers. The medication works by triggering the body's
immune
system to find and kill mutated cells on the outer layer of the skin.
"Standard skin cancer treatment options include scraping, burning,
radiation, or surgically removing cancer lesions from the skin, which
can be
uncomfortable and sometimes disfiguring," says Dr. Goldstein,
consultant
dermatologist at the University Health Network, Toronto Western
Hospital. "But
with the availability of ALDARA for sBCC, Canadians have another
effective
option, which is associated with little or no discomfort, and may not
cause
the long-term scarring that can be seen with more invasive treatments.
This
therapy can replace surgical options for superficial BCCs, with good
cure
rates and an acceptable side effect profile."
Skin cancer is the most common of all cancers affecting approximately
82,000 Canadians(1). Over the last 15 years its incidence has increased
by
two-thirds (67 per cent)(2). Basal cell carcinoma accounts for 80 per
cent of
all skin cancers(3).
"When I was diagnosed with basal cell carcinoma (BCC), I was shocked -
skin cancer was never something I was concerned about," says Canadian
Hall of
Fame and Senior PGA Championship golfer, David Barr. "Now I know the
importance of examining my skin regularly and seeing my doctor if I
notice
anything unusual. For many of us the damage from years of sun exposure
is
already done, so early detection is crucial. If caught early, BCC is
highly
treatable."
ALDARA is a cream that is applied at home by the patient and unlike
most
approved therapies, is non-invasive, which means it does not involve
surgery.
In clinical trials involving 364 patients with primary sBCCs, 82 per
cent of
patients treated with ALDARA achieved complete disease clearance
confirmed by
biopsy, compared with only three per cent in the placebo group(4).
"Finding effective and patient-friendly options is important in
advancing
the treatment of non-melanoma skin cancer," comments Dr. Jason Rivers,
dermatologist and active staff member at the British Columbia Cancer
Agency,
and professor of dermatology at the University of British Columbia in
Vancouver. "Not only is ALDARA effective, but it's exciting because it
works
with the body's own immune system to fight cancer from within, rather
than
treating it invasively from the outside."
ALDARA is applied five times per week, for six weeks, to sBCC lesions
with a maximum diameter of two centimetres, confirmed by biopsy,
located on
the trunk of the body, neck, or extremities (excluding hands and feet).
In
clinical trials, the most frequent reactions reported by ALDARA
patients were
local skin reactions, including erythema (redness), and scabbing at the
application site. Although 97 per cent of patients reported erythema,
only
three per cent reported pain and only one per cent of patients
discontinued
treatment due to local skin or application-site reactions. Scarring was
not
reported as a result of ALDARA treatment at the 12 week post-treatment
evaluation.
ALDARA was first approved by Health Canada in 1999 for the treatment of
external genital and perianal warts, caused by the human papillomavirus
(HPV).
In June 2004, Health Canada approved ALDARA for the treatment of
actinic
keratosis, a precancerous skin condition that can lead to squamous cell
carcinoma, another form of non-melanoma skin cancer.

Basal Cell Carcinoma
Basal cell carcinoma affects approximately 65,000 Canadians(5).
Superficial BCC is a type of BCC that typically occurs on the torso and
may
appear on the face. It appears as well-defined, red, scaly patches that
can
resemble eczema or psoriasis. Like other skin cancers, sBCC is caused
by over
exposure to the sun's damaging rays.
Basal cell carcinoma lesions generally grow slowly and have up to a
95 per cent treatment success rate if caught early(6). If left
untreated,
BCC tumours can continue to grow, eventually invading and causing
damage to
surrounding tissues.

3M Canada
3M Canada is the marketer of ALDARA. 3M Pharmaceuticals, a division of
3M Canada Company, develops, manufactures and sells prescription drug
products
related to dermatology, ual health, and respiratory conditions. 3M
Canada
Company employs over 1,800 people across Canada and has annual sales
exceeding
$1billion (CDN). Additional information is available at www.3m.ca
Worldwide, 3M Company is a $16 billion (US) diversified technology
company with leading positions in industrial, consumer, office, health
care,
safety and electronics, telecommunications and other markets.

3M and ALDARA are trademarks of 3M. Used under license in Canada.

NOTE TO TELEVISION STATIONS:
B-roll will be available on January 6, 2005 from 11:00 - 11:30 EST and
14:00 -14:30 EST at the following coordinates:
Anik E2F C Band, Transponder 5 Baker, audio subcarriers 6.2/6.8. Down
link frequency 3900 vertical polarity

References:
-----------------------------------
(1) National Cancer Institute of Canada: Canadian Cancer Statistics
2004.
(2) Ibid.
(3) Alam M, Datner D. Cutaneous squamous cell carcinoma. New Eng J Med.
2001; 334 (13): 975-983
(4) Geisse et.al. Imiquimod 5% cream for the treatment of superficial
basal cell carcinoma: Results from two phase III, randomized,
vehicle-controlled studies. J. Amer. Acad. Dermatol. May 2004:
722-733.
(5) National Cancer Institute of Canada: Canadian Cancer Statistics
2004.
(6) American Accreditation HealthCare Commission for Medline Plus
Medical
Encyclopedia: Basal cell carcinoma. Available at
http://www.nlm.nih.gov/medlineplus/ency/article/000824.htm
(Accessed October 19, 2004).

For further information: Environics Communications: Jennifer Casey,
(416) 969-2724, jcasey@environicspr.com; Sacha Tynan, (416) 969-2716,
stynan@environicspr.com

Who loves ya.
Tom

Jesus Was A Vegetarian! http://jesuswasavegetarian.7h.com
Man Is A Herbivore!
http://pages.ivillage.com/ironjustice/manisaherbivore
DEAD PEOPLE WALKING
http://pages.ivillage.com/ironjustice/deadpeoplewalking

From:	Tom
Subject:	Re: New Cream Treatment for Skin Cancer
Date:	Thu, 20 Jan 2005 21:58:43 GMT

I've been using Aldara for the past 12 months for Actinic Keritosis (pre
cancerous) and it work fine.
It was originally used for genitle herpes, but was found to have this use
too. I found it easy to use
except on some spots that were in the hair. A little bothersome applying at
night and scrubbing off in the
morning, but it worked great, even caused a couple of spots that wern't
visible to the eye to scale over
and disappear. Good stuff. My doc says not as much touble as what she
prescribed before which was
a cancer chemotherapy in salve form.
Tom
wrote in message
news:1106253636.175524.116550@f14g2000cwb.googlegroups.com...
> http://www.newswire.ca/en/releases/archive/January2005/06/c0426.html
>
> Health Canada Approves New Cream Treatment for Skin Cancer
> ALDARA is the first new treatment approved in Canada
> for basal cell carcinoma in 30 years
>
> Pro Golfer David Barr urges Canadians
> to take action against skin cancer
>
> TORONTO, Jan. 6 /CNW/ - Health Canada has approved ALDARA(TM)
> (imiquimod)
> Cream, 5%, a topical prescription medication for the treatment of
> superficial
> basal cell carcinoma (sBCC) - a form of non-melanoma skin cancer.
> ALDARA is
> the first new treatment for this type of cancer to be approved in
> Canada in
> close to 30 years and is the first in a new class of medications called
> immune
> response modifiers. The medication works by triggering the body's
> immune
> system to find and kill mutated cells on the outer layer of the skin.
> "Standard skin cancer treatment options include scraping, burning,
> radiation, or surgically removing cancer lesions from the skin, which
> can be
> uncomfortable and sometimes disfiguring," says Dr. Goldstein,
> consultant
> dermatologist at the University Health Network, Toronto Western
> Hospital. "But
> with the availability of ALDARA for sBCC, Canadians have another
> effective
> option, which is associated with little or no discomfort, and may not
> cause
> the long-term scarring that can be seen with more invasive treatments.
> This
> therapy can replace surgical options for superficial BCCs, with good
> cure
> rates and an acceptable side effect profile."
> Skin cancer is the most common of all cancers affecting approximately
> 82,000 Canadians(1). Over the last 15 years its incidence has increased
> by
> two-thirds (67 per cent)(2). Basal cell carcinoma accounts for 80 per
> cent of
> all skin cancers(3).
> "When I was diagnosed with basal cell carcinoma (BCC), I was shocked -
> skin cancer was never something I was concerned about," says Canadian
> Hall of
> Fame and Senior PGA Championship golfer, David Barr. "Now I know the
> importance of examining my skin regularly and seeing my doctor if I
> notice
> anything unusual. For many of us the damage from years of sun exposure
> is
> already done, so early detection is crucial. If caught early, BCC is
> highly
> treatable."
> ALDARA is a cream that is applied at home by the patient and unlike
> most
> approved therapies, is non-invasive, which means it does not involve
> surgery.
> In clinical trials involving 364 patients with primary sBCCs, 82 per
> cent of
> patients treated with ALDARA achieved complete disease clearance
> confirmed by
> biopsy, compared with only three per cent in the placebo group(4).
> "Finding effective and patient-friendly options is important in
> advancing
> the treatment of non-melanoma skin cancer," comments Dr. Jason Rivers,
> dermatologist and active staff member at the British Columbia Cancer
> Agency,
> and professor of dermatology at the University of British Columbia in
> Vancouver. "Not only is ALDARA effective, but it's exciting because it
> works
> with the body's own immune system to fight cancer from within, rather
> than
> treating it invasively from the outside."
> ALDARA is applied five times per week, for six weeks, to sBCC lesions
> with a maximum diameter of two centimetres, confirmed by biopsy,
> located on
> the trunk of the body, neck, or extremities (excluding hands and feet).
> In
> clinical trials, the most frequent reactions reported by ALDARA
> patients were
> local skin reactions, including erythema (redness), and scabbing at the
> application site. Although 97 per cent of patients reported erythema,
> only
> three per cent reported pain and only one per cent of patients
> discontinued
> treatment due to local skin or application-site reactions. Scarring was
> not
> reported as a result of ALDARA treatment at the 12 week post-treatment
> evaluation.
> ALDARA was first approved by Health Canada in 1999 for the treatment of
> external genital and perianal warts, caused by the human papillomavirus
> (HPV).
> In June 2004, Health Canada approved ALDARA for the treatment of
> actinic
> keratosis, a precancerous skin condition that can lead to squamous cell
> carcinoma, another form of non-melanoma skin cancer.
>
> Basal Cell Carcinoma
> Basal cell carcinoma affects approximately 65,000 Canadians(5).
> Superficial BCC is a type of BCC that typically occurs on the torso and
> may
> appear on the face. It appears as well-defined, red, scaly patches that
> can
> resemble eczema or psoriasis. Like other skin cancers, sBCC is caused
> by over
> exposure to the sun's damaging rays.
> Basal cell carcinoma lesions generally grow slowly and have up to a
> 95 per cent treatment success rate if caught early(6). If left
> untreated,
> BCC tumours can continue to grow, eventually invading and causing
> damage to
> surrounding tissues.
>
> 3M Canada
> 3M Canada is the marketer of ALDARA. 3M Pharmaceuticals, a division of
> 3M Canada Company, develops, manufactures and sells prescription drug
> products
> related to dermatology, ual health, and respiratory conditions. 3M
> Canada
> Company employs over 1,800 people across Canada and has annual sales
> exceeding
> $1billion (CDN). Additional information is available at www.3m.ca
> Worldwide, 3M Company is a $16 billion (US) diversified technology
> company with leading positions in industrial, consumer, office, health
> care,
> safety and electronics, telecommunications and other markets.
>
> 3M and ALDARA are trademarks of 3M. Used under license in Canada.
>
> NOTE TO TELEVISION STATIONS:
> B-roll will be available on January 6, 2005 from 11:00 - 11:30 EST and
> 14:00 -14:30 EST at the following coordinates:
> Anik E2F C Band, Transponder 5 Baker, audio subcarriers 6.2/6.8. Down
> link frequency 3900 vertical polarity
>
>
> References:
> -----------------------------------
> (1) National Cancer Institute of Canada: Canadian Cancer Statistics
> 2004.
> (2) Ibid.
> (3) Alam M, Datner D. Cutaneous squamous cell carcinoma. New Eng J Med.
> 2001; 334 (13): 975-983
> (4) Geisse et.al. Imiquimod 5% cream for the treatment of superficial
> basal cell carcinoma: Results from two phase III, randomized,
> vehicle-controlled studies. J. Amer. Acad. Dermatol. May 2004:
> 722-733.
> (5) National Cancer Institute of Canada: Canadian Cancer Statistics
> 2004.
> (6) American Accreditation HealthCare Commission for Medline Plus
> Medical
> Encyclopedia: Basal cell carcinoma. Available at
> http://www.nlm.nih.gov/medlineplus/ency/article/000824.htm
> (Accessed October 19, 2004).
>
>
>
> For further information: Environics Communications: Jennifer Casey,
> (416) 969-2724, jcasey@environicspr.com; Sacha Tynan, (416) 969-2716,
> stynan@environicspr.com
>
> Who loves ya.
> Tom
>
> Jesus Was A Vegetarian! http://jesuswasavegetarian.7h.com
> Man Is A Herbivore!
> http://pages.ivillage.com/ironjustice/manisaherbivore
> DEAD PEOPLE WALKING
> http://pages.ivillage.com/ironjustice/deadpeoplewalking
>

From:	Mark & Steven Bornfeld DDS
Subject:	Re: New Cream Treatment for Skin Cancer
Date:	Thu, 20 Jan 2005 16:12:00 -0500

ironjustice@aol.com wrote:

> http://www.newswire.ca/en/releases/archive/January2005/06/c0426.html
>
> Health Canada Approves New Cream Treatment for Skin Cancer
> ALDARA is the first new treatment approved in Canada
> for basal cell carcinoma in 30 years
>
> Pro Golfer David Barr urges Canadians
> to take action against skin cancer
>
> TORONTO, Jan. 6 /CNW/ - Health Canada has approved ALDARA(TM)
> (imiquimod)
> Cream, 5%, a topical prescription medication for the treatment of
> superficial
> basal cell carcinoma (sBCC) - a form of non-melanoma skin cancer.
>

Aldara was prescribed for our daughter for some plantar warts a year or
so ago. This was after she freaked when the dermatologist removed
another wart on her finger with liquid N2. I was dubious, especially
when I questioned him later and he said it "might" work. I was even
more dubious when I had to pay for this wonder cream--I think it was
about $150 for a couple of weeks supply.
It took a couple of months of soaking, applying, and rubbing, but the
stuff worked. Hope it works as well on the basal cell ca.

Steve

--
Mark & Steven Bornfeld DDS
http://www.dentaltwins.com
Brooklyn, NY
718-258-5001

From:	madiba
Subject:	Re: New Cream Treatment for Skin Cancer
Date:	Fri, 21 Jan 2005 16:59:24 +0100

Mark & Steven Bornfeld DDS wrote:

> ironjustice@aol.com wrote:
>
> > http://www.newswire.ca/en/releases/archive/January2005/06/c0426.html
> >
> > Health Canada Approves New Cream Treatment for Skin Cancer
> > ALDARA is the first new treatment approved in Canada
> > for basal cell carcinoma in 30 years
> >
> > Pro Golfer David Barr urges Canadians
> > to take action against skin cancer
> >
> > TORONTO, Jan. 6 /CNW/ - Health Canada has approved ALDARA(TM)
> > (imiquimod)
> > Cream, 5%, a topical prescription medication for the treatment of
> > superficial
> > basal cell carcinoma (sBCC) - a form of non-melanoma skin cancer.
> >
>
> Aldara was prescribed for our daughter for some plantar warts a year or
> so ago. This was after she freaked when the dermatologist removed
> another wart on her finger with liquid N2. I was dubious, especially
> when I questioned him later and he said it "might" work. I was even
> more dubious when I had to pay for this wonder cream--I think it was
> about $150 for a couple of weeks supply.
>It took a couple of months of soaking, applying, and rubbing, but the
> stuff worked. Hope it works as well on the basal cell ca.
>
> Steve
Hi Steve, long time no read (I got tired of the amalgam discussions)
You're lucky it worked for plantar warts, they are often quite deep.
It should be fine for BCCs, as long as they're superficial. Aldara is
even beeing tested on 'real' cancers like anal cancer now, again the
indication is that the tumors are small, no deep infiltration.
Guess its time to get shares in 3M, seeing that they are taking away
some of my work..!

madiba

From:	scambuster
Subject:	Re: New Cream Treatment for Skin Cancer
Date:	Fri, 21 Jan 2005 03:59:49 -0500

Searched all groups Results 11 - 17 of 17 for " 700290117129". (0.07
seconds)

"ironjustice@aol.com" wrote:

From:	zest_fien at yahoo.com
Subject:	Re: New Cream Treatment for Skin Cancer
Date:	20 Jan 2005 19:48:17 -0800

-------------
US|UK|EU|Australia|New Zealand|Chile|Brazil|India|China|Japan|South
Korea|Singapore|Malaysia|Indonesia|Philippines|Thailand|Vietnam|
(PRWEB/PRNewsWire/CNN/AFP/AP/Fox/NewsCorp/Reuters/Bloomberg/Bridge/UPI)

January 20, 2005 -- Naturalis announces the official launch of its
website www.naturalisproducts.com to expand and promote its natural
range of skin, body, hair and sensual care worldwide.

Accommodating all skin types from normal or dry to oily, sensitive or
acneic, even rosacea and pigmentation, Naturalis range of skin care
products aims to encourage the renewal of healthy cells, cleansing,
moisturising and smoothening the skin. Naturalis skin care products are
developed through the selective use of herbs, spices, essential oils,
nuts and botanical extracts that are safe and deliver desirable
results. Naturalis products are suitable for all ages of men, women and
infants.

"Our range of products is just not treating skin. They are formulated
to treat the skin at a deeper cellular level in a way that will
encourage healthier cells growth," said Mr. Arnold K.C, Business
Manager, Naturalis. "Our products have produced amazing results that
our customers are very happy with. Most importantly, our products are
safe and free from any petrochemicals and its derivative, parabens,
synthetic fillers, sulphates, propylene glycol, artificial colours and
fragrances."

Naturalis offers over 19 skin care treatments on its website. Through
global distributor's network, our products are sold around the world.
Naturalis will continue to research and develop new products that the
market demands and explore new markets so that more customers can have
easy access to our products. To facilitate easy purchase, we will
continue to appoint more distributors worldwide for this purpose.

To learn more about Naturalis products, our skin, body, hair, sensual
care and beauty approach, please visit www.naturalisproducts.com.

Alternatively, we can be contacted via email at:
sales@naturalisproducts.com or telephone number +65 8139 6443.

From:	ironjustice at aol.com
Subject:	Re: New Cream Treatment for Skin Cancer
Date:	20 Jan 2005 13:05:49 -0800

I find it kind of .. odd .. Steph .. hasn't mentioned .. this ..

But .. hey .. it looks like it may cut INTO .. some of his .. work for
pay ..

Heh .. heh ..

Who loves ya.
Tom

Jesus Was A Vegetarian! http://jesuswasavegetarian.7h.com
Man Is A Herbivore!
http://pages.ivillage.com/ironjustice/manisaherbivore
DEAD PEOPLE WALKING
http://pages.ivillage.com/ironjustice/deadpeoplewalking

From:	Blow, Joe
Subject:	Re: New Cream Treatment for Skin Cancer
Date:	Thu, 20 Jan 2005 20:35:53 -0500

ironjustice@aol.com wrote:

> I find it kind of .. odd .. Steph .. hasn't mentioned .. this ..
>
> But .. hey .. it looks like it may cut INTO .. some of his .. work for
> pay ..

21% had recurrences at 2 years
http://www.pharmacist.com/articles/h_ts_0585.cfm
Aldara approved for superficial basal cell carcinoma
Surgery still preferred, but topical cream offers alternative.

FDA has approved an additional indication for imiquimod (Aldara—3M
Pharmaceuticals): treatment of superficial basal cell carcinoma (sBCC) on
the body, neck, arms, or legs, but not the face. The topical cream was
previously approved for treatment of actinic keratosis and external
genital warts

sBCC has been treated by surgical removal, and that remains the preferred
therapy because it is more effective than imiquimod. Imiquimod should be
used only when surgery is medically less appropriate. Patients treated
with imiquimod for sBCC should have regular follow-up visits after
treatment to make sure the skin cancer is completely treated.

The safety and effectiveness of imiquimod were established in two
double-blind controlled studies with 364 patients. In these studies, 75%
of 185 patients who had their sBCC treated with imiquimod had no evidence
clinically or on repeat biopsy of their sBCC at 12 weeks after finishing
treatment. In a separate long-term study involving 182 patients, 79% had
no evidence of their sBCC at 2 years after finishing treatment.

Most patients using imiquimod for the treatment of sBCC experienced skin
reactions at the treatment site, which included redness, swelling, a sore
or blister, peeling, itching, and burning.

From:	Steph
Subject:	Re: New Cream Treatment for Skin Cancer
Date:	Fri, 21 Jan 2005 02:33:33 GMT

wrote in message
news:1106253636.175524.116550@f14g2000cwb.googlegroups.com...

Any old iron
Any old iron
Any, any, any old iron
You look sweet
Talk about a treat
You look dapper from your napper to yer feet.......